MeSH tree: C10.228
A recent study published in Otolaryngology–Head and Neck Surgery finds that two common and treatable causes of conductive hearing loss—eardrum perforations and cholesteatoma, a type of abnormal skin growth in the middle ear—are ...
Apr 13, 2026
0
6
Air pollution just isn't what it used to be. While levels of lead and sulfur dioxide have dropped due to environmental regulations, other threats to air quality persist.
Apr 13, 2026
0
1
Scientists at the Buck Institute for Research on Aging, along with collaborators at UC San Francisco, have discovered that APOE4, the most common genetic risk factor for Alzheimer's disease, causes bone quality deficits specifically ...
Apr 13, 2026
0
6
Knowing whether a child has sustained a concussion is an important matter to clinicians, parents and bystanders alike. However, the signs and symptoms that are most meaningful to look for are not as well defined. A study ...
Apr 13, 2026
0
16
Neuroscientists from Monash University, the University of Melbourne and University College London are calling for clinical studies to understand the causes of brain fog in menopause and find effective treatments.
Apr 13, 2026
0
2
A prespecified analysis of the NOAH-AFNET 6 trial investigated the impact of kidney function on cardiovascular outcome in patients with device-detected atrial fibrillation. Today, the findings were presented by AFNET board ...
Apr 13, 2026
0
3
Labels like autism, attention deficit hyperactivity disorder (ADHD) and dyslexia are not new. But the way we understand them is changing.
Apr 13, 2026
0
4
A new study, published in JAMA Network Open, reveals that school-age children and adolescents with medically diagnosed traumatic brain injury (TBI) have significantly higher rates of anxiety/depression, and strong family ...
Apr 13, 2026
0
6
A new study has found that combining the current medications for Alzheimer's disease with small molecules derived from micronutrients found in grapes, berries, peanuts and turmeric is a safer and more effective way to treat ...
Apr 11, 2026
0
31
An experimental drug designed to silence a gene strongly linked to Parkinson's disease has shown encouraging effects in a first-in-human clinical trial, according to a study published in Nature Medicine. The drug, known as ...
Apr 11, 2026
0
32
